XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jan. 28, 2023
Jan. 29, 2022
Cash Flows from Operating Activities    
Net loss $ (121,489) $ (32,739)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Change in inventory reserves (6,413) 445
Stock-based compensation expense 57,581 64,713
Depreciation, amortization, and accretion 22,095 17,374
Asset impairment 16,874 0
Other 1,067 7
Change in operating assets and liabilities:    
Inventory 44,896 28,100
Prepaid expenses and other assets 8,938 (5,755)
Income tax receivables 26,640 43
Operating lease right-of-use assets and liabilities (111) 4,855
Accounts payable (38,678) 51,296
Accrued liabilities (3,840) (4,267)
Deferred revenue (1,016) (3,699)
Gift card liability 1,938 3,261
Other liabilities 2,578 1,298
Net cash provided by operating activities 11,060 124,932
Cash Flows from Investing Activities    
Purchases of property and equipment (11,886) (30,900)
Purchases of securities available-for-sale (258) (77,532)
Sales of securities available-for-sale 4,144 4,690
Maturities of securities available-for-sale 11,210 76,109
Net cash provided by (used in) investing activities 3,210 (27,633)
Cash Flows from Financing Activities    
Proceeds from the exercise of stock options, net 154 1,365
Payments for tax withholdings related to vesting of restricted stock units (6,969) (23,372)
Repurchase of common stock 0 (9,996)
Other (117) 0
Net cash used in financing activities (6,932) (32,003)
Net increase in cash and cash equivalents 7,338 65,296
Effect of exchange rate changes on cash and cash equivalents 706 (1,203)
Cash and cash equivalents at beginning of period 130,935 129,785
Cash and cash equivalents at end of period 138,979 193,878
Supplemental Disclosure    
Cash paid for income taxes 178 389
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Purchases of property and equipment included in accounts payable and accrued liabilities 1,430 3,040
Capitalized stock-based compensation 3,409 3,682
Repurchase of common stock included in accrued liabilities $ 0 $ 1,000